Year None202420232022202120202019201820172016 Date Latest Press Release March 5, 2018 Eiger Announces Abstracts and Presentations of LOWR HDV Program and Planned Registration Program at The International Liver Congress™ Meeting February 6, 2018 Eiger BioPharmaceuticals to Participate in Two Upcoming Investor Conferences in February January 16, 2018 Eiger BioPharmaceuticals Announces Phase 2 LIBERTY Study in Pulmonary Arterial Hypertension Did Not Meet Primary Endpoint January 8, 2018 Eiger BioPharmaceuticals Announces Appointment of Commercial Operations Industry Veteran Eldon Mayer to its Board of Directors January 4, 2018 Eiger BioPharmaceuticals Completes Enrollment of Phase 2 ULTRA Study of Ubenimex in Primary and Secondary Lymphedema Patients January 3, 2018 Eiger BioPharmaceuticals Appoints David Apelian, MD, PhD, MBA Chief Operating Officer and Executive Medical Officer January 2, 2018 Eiger BioPharmaceuticals to Present at Biotech Showcase™ 2018 November 13, 2017 Eiger BioPharmaceuticals to Present at Jefferies 2017 Healthcare Conference November 9, 2017 Eiger BioPharmaceuticals Reports Third Quarter 2017 Financial Results November 6, 2017 Eiger BioPharmaceuticals to Participate in Upcoming Investor Conferences Pagination First page « first Previous page ‹ previous … Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Page 21 Page 22 … Next page next › Last page last »